Srinivas Akkaraju
Director; Director, 10% Owner · 8 filings · Latest: Sep 4, 2026
ALUMIS INC.
Kalaris Therapeutics, Inc.
Mineralys Therapeutics, Inc.
Scholar Rock Holding Corp
vTv Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ALMS | Srinivas Akkaraju | Director | Sep 8, 2026 | Purchase | $10.63 | 546,581 | $5.8M | 2,298,783 | |
ALMS | Srinivas Akkaraju | Director | Sep 8, 2026 | Sale | $10.55 | 96,131 | $1.0M | 2,025,493 | |
ALMS | Srinivas Akkaraju | Director | Sep 4, 2026 | Purchase | $11.17 | 440,140 | $4.9M | 2,073,558 | |
KLRS | Srinivas Akkaraju | Director, 10% Owner | May 20, 2026 | Purchase | $4.83 | 244,300 | $1.2M | 2,224,147 | |
KLRS | Srinivas Akkaraju | Director, 10% Owner | Dec 18, 2025 | Purchase | $10.42 | 479,847 | $5.0M | 1,979,847 | |
— | AKKARAJU SRINIVAS | — | Dec 30, 2024 | Proposed Sale | $0.2471 | 9,333 | $2.3K | — | |
SRRK | AKKARAJU SRINIVAS | — | Oct 7, 2024 | Proposed Sale | $29.25 | 1,175,713 | $34.4M | — |